Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire de Saint Etienne
We propose a pilot study of CA9 serum in patients with adenocarcinoma metastatic cell treated by conventional immunotherapy and / or targeted therapy. This pilot study aims to test the CA9 serum marker of response to medical treatment
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Conventional renal cell cancer with a pathological diagnosis